Role of ABeta-Degrading Proteases in Alzheimer's Disease
Role of ABeta-Degrading Proteases in Alzheimer's Disease
批准号:
7097935
负责人:
WESLEY FARRIS
金额:
$17.52万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-07-31
关键词:
Alzheimer&aposs diseaseamyloid proteinsbiotransformationdisease /disorder modelendopeptidasesenzyme activityenzyme linked immunosorbent assaygene deletion mutationgenetic polymorphismgenetically modified animalsimmunocytochemistrylaboratory mouselaboratory ratneprilysinnoninsulin dependent diabetes mellitusphenotypepolymerase chain reactionprotein degradationprotein isoformsreporter genes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Although an impressive number of studies support a central role for amyloid beta-protein (A beta) in the pathogenesis of Alzheimer's disease (AD), in the vast majority of cases, the underlying causes for the peptide's accumulation are unknown. Overproduction of A beta has been implicated in only a few cases (<5%), and newly generated AB is rapidly cleared from the brain, suggesting that A beta-degrading proteases could play a vital role in regulating cerebral levels of the peptide. Although much work has focused on the generation of A beta, relatively little is known about A beta proteolysis, which could be equally or even more important in the pathogenesis and/or potential treatments of AD. The two best-studied A beta-degrading proteases are neprilysin (NEP) and insulin-degrading enzyme (IDE). There is human genetic evidence showing linkage of the IDE region of chromosome 10q to both AD and type 2 diabetes mellitus (DM2) in some populations, which is intriguing in light of the growing evidence that DM2 and hyperinsulinemia are associated with an increased risk of developing AD. The central hypothesis of this proposal is that IDE and NEP are important regulators of A beta levels in vivo and defects in these proteases may underlie some cases of AD. My Aims are to: 1) Determine whether dysfunction of IDE leads to decreased A beta and insulin catabolism in vivo using two animal models, 2) Assess the relative roles in vivo of IDE and NEP in the metabolism of the human isoform of A beta by breeding gene-deleted mice to human APP transgenic mice, 3) Determine the biological significance of the known polymorphisms in the 5' un-translated region (UTR) of the IDE gene in AD families with allelic association to this region of chromosome 10q by quantifying transcripts and using reporter constructs and 4) Examine several aspects of the normal cell biology of IDE, such as a possible GPI-anchor, isoforms in the CSF and serum, and search for natural binding partners. The goal of this K08 proposal is to obtain the necessary scientific training in cell and molecular biology, animal breeding strategies, and statistical analysis to allow the candidate to test the above hypothesis as outlined, and in doing so, allow the candidate to develop into a successful and independent physician-scientist with the skills to help individuals with neurodegenerative dementias. The candidate's career development plan, world-class training environment, and commitment from his Department will allow the realization of this goal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ABeta-Degrading Proteases in Alzheimer's Disease
-
批准号:6925441
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2003
-
负责人:WESLEY FARRIS
-
依托单位:
Role of ABeta-Degrading Proteases in Alzheimer's Disease
-
批准号:6779702
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2003
-
负责人:WESLEY FARRIS
-
依托单位:
Role of ABeta-Degrading Proteases in Alzheimer's Disease
-
批准号:7277769
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2003
-
负责人:WESLEY FARRIS
-
依托单位:
Role of ABeta-Degrading Proteases in Alzheimer's Disease
-
批准号:6670137
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2003
-
负责人:WESLEY FARRIS
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: